Alpha Tau will also host an R&D Update Day on Monday, January 27, 2025 at 11am ET, during which the Company will review the new data shared at the symposium and additional data from the Company’s ...
Coherus BioSciences, Inc. ("Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical trial evaluating casdozokitug (casdozo), a ...